Tumour‐infiltrating Tregs inhibit anti‐tumour immune response via several pathways, including the production of immunosuppressive cytokines, PD‐1 checkpoint inhibition and up‐regulation membrane protein PD‐1 and CTLA‐4,58, 59 ultimately facilitating tumour metastasis.60 The gene discussed is CTLA4; the disease is neoplasm.